A Psychedelics Reporter With a Changing Perspective
Can an experimental drug cure opioid addiction? Andrew Jacobs, who writes about psychedelic medicine for The Times, explored the “promise and peril” of ibogaine.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.